The historical rank and industry rank for Shandong Keyuan Pharmaceutical Co's OCF Margin % or its related term are showing as below:
SZSE:301281'
s OCF Margin % Range Over the Past 10 Years
Min: -13.05 Med: 9.6 Max: 28.65
Current: 16.76
During the past 13 years, the highest OCF Margin % of Shandong Keyuan Pharmaceutical Co was 28.65%. The lowest was -13.05%. And the median was 9.60%.
SZSE:301281's OCF Margin % is ranked better than 70.54% of 964
companies
in the Drug Manufacturers industry
Industry Median: 10.035
vs SZSE:301281: 16.76
Shandong Keyuan Pharmaceutical Co OCF Margin % Related Terms
Shandong Keyuan Pharmaceutical Co OCF Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Keyuan Pharmaceutical Co OCF Margin % Chart
SZSE:301281 vs LLY, JNJ, ABBV: OCF Margin % Comparison
For the Drug Manufacturers - General subindustry, Shandong Keyuan Pharmaceutical Co's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shandong Keyuan Pharmaceutical Co OCF Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Shandong Keyuan Pharmaceutical Co's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Shandong Keyuan Pharmaceutical Co's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shandong Keyuan Pharmaceutical Co (SZSE:301281) has a OCF Margin % of 19.29% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Shandong Keyuan Pharmaceutical Co and its competitors. This is 101% above median its historical median of 9.60. According to the industry distribution chart, Shandong Keyuan Pharmaceutical Co ranks #284 out of 964 companies in the Drug Manufacturers industry, placing it in the top 29.5%.
Is Shandong Keyuan Pharmaceutical Co's OCF Margin % too high?
Shandong Keyuan Pharmaceutical Co's current OCF Margin % of 19.29% is 101% above median its 10-year median of 9.60. The Drug Manufacturers industry median OCF Margin % is 10.04. Shandong Keyuan Pharmaceutical Co's value of 19.29% is 92.2% above this industry median. Based on the distribution chart, Shandong Keyuan Pharmaceutical Co ranks #284 out of 964 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Shandong Keyuan Pharmaceutical Co has a GF Score™ of 67/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Shandong Keyuan Pharmaceutical Co's OCF Margin % compare to LLY and JNJ?
According to the Drug Manufacturers industry distribution chart, Shandong Keyuan Pharmaceutical Co ranks #284 out of 964 companies for OCF Margin %. This puts Shandong Keyuan Pharmaceutical Co in the upper half of its industry. The industry median OCF Margin % is 10.04. Shandong Keyuan Pharmaceutical Co's value of 19.29% is 92.2% above this benchmark. While the company's 10-year median is 9.60 vs. the industry median of 10.04, Shandong Keyuan Pharmaceutical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Drug Manufacturers company?
The median OCF Margin % among Drug Manufacturers companies is 10.04, based on 964 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shandong Keyuan Pharmaceutical Co's current OCF Margin % of 19.29% is 92.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Shandong Keyuan Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median OCF Margin % is 10.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shandong Keyuan Pharmaceutical Co's current OCF Margin % is 19.29%, which is 101% above median its own 10-year median of 9.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shandong Keyuan Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co (SZSE:301281) is currently considered Significantly Overvalued. The stock's GF Value™ is ¥30.41, compared to a current price of ¥50.42 — trading 65.8% above its estimated fair value. The current OCF Margin % is 19.29%, which is 101% above median its 10-year median of 9.60 and 92.2% above the Drug Manufacturers industry median of 10.04. Shandong Keyuan Pharmaceutical Co's overall GF Score™ is 67/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Shandong Keyuan Pharmaceutical Co (SZSE:301281), the current OCF Margin % is 19.29% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shandong Keyuan Pharmaceutical Co (SZSE:301281) Overvalued in 2026?
Based on GuruFocus' analysis, Shandong Keyuan Pharmaceutical Co stock appears to be overvalued.
The current stock price of ¥50.42 is trading 65.8% above its estimated GF Value™ of ¥30.41.
GuruFocus considers Shandong Keyuan Pharmaceutical Co to be Significantly Overvalued.
Key valuation signals for SZSE:301281:
OCF Margin %: 19.29% (101% above median its 10-year median of 9.60)
GF Value™: ¥30.41 vs. price of ¥50.42 (65.8% above fair value)
Industry Position: 92.2% above the Drug Manufacturers median (#284 of 964)
No single metric tells the full story. See the SZSE:301281 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shandong Keyuan Pharmaceutical Co Business Description
Shandong Keyuan Pharmaceutical Co Ltd is engaged in the research and development, production, and sales of chemical raw materials and their preparations.
67GF Score
Get the complete analysis for SZSE:301281
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SZSE:301281 has been successfully added to your 
